Y10S 424/803
Antibody or antigen-binding fragment thereof that binds gram-negative bacteria
Y10S424/803 (Antibody or antigen-binding fragment thereof that binds gram-negative bacteria) appears on 15 US grants and 6 published applications in this corpus.
Search patents in Y10S- Granted patents
- 15
- Published applications
- 6
- Assignees
- 13
- Inventors
- 34
- Latest grant
- 11 May 2010
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 2 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Specific avian egg antibodies for disease prevention and improvement of growth performance11 May 2010US 7,713,527 B2
- Vaccine against Gram-negative bacterial infections26 Jun 2007US 7,235,644 B2The United States of America as represented by the Secretary of the Army
- Vaccine against Gram-negative bacterial infections11 Apr 2006US 7,025,963 B1The United States of America as represented by the Secretary of the Army
- Vaccine against Gram-negative bacterial infections28 Mar 2006US 7,018,636 B1The United States of America as represented by the Secretary of the Army
- Products comprising inactivated yeasts or moulds provided with active antibodies11 Feb 2003US 6,517,829 B1Unilever Patent Holdings B.V.
- Antibodies as Growth Promoting Agents29 Mar 2007US 2007/0071795 A1
- Vaccine against Gram-negative bacterial infections20 Jul 2006US 2006/0159702 A1U.S. Government Dept. of the Army
- High molecular weight major outer membrane protein of Moraxella11 Sep 2003US 2003/0170657 A1
- High molecular weight major outer membrane protein of Moraxella11 Sep 2003US 2003/0171254 A1
- High molecular weight major outer membrane protein of moraxella6 Jun 2002US 2002/0068070 A1Aventis Pasteur Limited
Most cited
By later US patents
- Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants92US 5,585,098 AOvimmune, Inc. · 1996
- Monoclonal antibodies reactive with endotoxin core37US 5,057,598 ACentocor, Inc. · 1991
- Vaccine against Gram-negative bacterial infections18US 7,018,636 B1The United States of America as represented by the Secretary of the Army · 2006
- Protective monoclonal antibody compositions for infections due to group B streptococcus16US 4,970,070 AGenetic Systems Corporation · 1990
- Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production15US 4,834,975 AMiles Inc. · 1989